In a study, increased RANKL and decreased OPG/RANKL ratios were determined in individuals with RA before methotrexate treatment compared with the healthy group, whereas an increase in the OPG/RANKL ratio was observed after at least 6 months of methotrexate treatment [2]. This evidence concerns the gene TNFSF11 and rheumatoid arthritis.